BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20818423)

  • 1. The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer.
    Moore HC; Jordan LB; Bray SE; Baker L; Quinlan PR; Purdie CA; Thompson AM; Bourdon JC; Fuller-Pace FV
    Oncogene; 2010 Dec; 29(49):6475-84. PubMed ID: 20818423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers.
    Iyer RS; Nicol SM; Quinlan PR; Thompson AM; Meek DW; Fuller-Pace FV
    Cell Cycle; 2014; 13(9):1413-23. PubMed ID: 24626184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage.
    Nicol SM; Bray SE; Black HD; Lorimore SA; Wright EG; Lane DP; Meek DW; Coates PJ; Fuller-Pace FV
    Oncogene; 2013 Jul; 32(29):3461-9. PubMed ID: 22986526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the RNA helicase p68 (Ddx5) as a transcriptional regulator.
    Nicol SM; Fuller-Pace FV
    Methods Mol Biol; 2010; 587():265-79. PubMed ID: 20225156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor.
    Bates GJ; Nicol SM; Wilson BJ; Jacobs AM; Bourdon JC; Wardrop J; Gregory DJ; Lane DP; Perkins ND; Fuller-Pace FV
    EMBO J; 2005 Feb; 24(3):543-53. PubMed ID: 15660129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of p68 RNA Helicase (DDX5) Activates a Survival Pathway Involving mTOR and MDM2 Signals.
    Kokolo M; Bach-Elias M
    Folia Biol (Praha); 2017; 63(2):52-59. PubMed ID: 28557706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
    Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
    Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.
    Jacobs AM; Nicol SM; Hislop RG; Jaffray EG; Hay RT; Fuller-Pace FV
    Oncogene; 2007 Aug; 26(40):5866-76. PubMed ID: 17369852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer.
    Hashemi V; Masjedi A; Hazhir-Karzar B; Tanomand A; Shotorbani SS; Hojjat-Farsangi M; Ghalamfarsa G; Azizi G; Anvari E; Baradaran B; Jadidi-Niaragh F
    J Cell Physiol; 2019 May; 234(5):5478-5487. PubMed ID: 30417346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.
    Horikawa I; Park KY; Isogaya K; Hiyoshi Y; Li H; Anami K; Robles AI; Mondal AM; Fujita K; Serrano M; Harris CC
    Cell Death Differ; 2017 Jun; 24(6):1017-1028. PubMed ID: 28362428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.
    Mooney SM; Goel A; D'Assoro AB; Salisbury JL; Janknecht R
    J Biol Chem; 2010 Oct; 285(40):30443-52. PubMed ID: 20663877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
    Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
    Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential.
    Mooney SM; Grande JP; Salisbury JL; Janknecht R
    Biochemistry; 2010 Jan; 49(1):1-10. PubMed ID: 19995069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Δ133p53 mRNA in lung carcinoma corresponds with reduction of p21 expression.
    Fragou A; Tzimagiorgis G; Karageorgopoulos C; Barbetakis N; Lazopoulos A; Papaioannou M; Haitoglou C; Kouidou S
    Mol Med Rep; 2017 Apr; 15(4):1455-1460. PubMed ID: 28260096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P68 RNA helicase as a molecular target for cancer therapy.
    Dai TY; Cao L; Yang ZC; Li YS; Tan L; Ran XZ; Shi CM
    J Exp Clin Cancer Res; 2014 Aug; 33(1):64. PubMed ID: 25150365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter.
    Marcel V; Vijayakumar V; Fernández-Cuesta L; Hafsi H; Sagne C; Hautefeuille A; Olivier M; Hainaut P
    Oncogene; 2010 May; 29(18):2691-700. PubMed ID: 20190805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence.
    Fujita K; Mondal AM; Horikawa I; Nguyen GH; Kumamoto K; Sohn JJ; Bowman ED; Mathe EA; Schetter AJ; Pine SR; Ji H; Vojtesek B; Bourdon JC; Lane DP; Harris CC
    Nat Cell Biol; 2009 Sep; 11(9):1135-42. PubMed ID: 19701195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
    Oh L; Hainaut P; Blanchet S; Ariffin H
    BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.